CHU YU-WAYE (Chief Medical Officer) sold 10.1% of their position (21.28K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $136.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2026ACC: 0001610717-26-000125
Officer· Chief Medical Officer
Since Feb 2026
-21.28K
Net shares
Net seller
$136.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
21.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−21.28K
Price / share
$6.42
Trade value
$136.68K
% of position
10.1%
3/17/2026
210.72K→189.45K
Total
Net shares
−21.28K
Net value
-$136.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −21.28K | $6.42 | $136.68K | 10.1% | 210.72K | 189.45K |
| Total | −21.28K | -$136.68K | ||||||
Derivative Transactions0
No derivative transactions reported